SAGE THERAPEUTICS for SAGE THERAPEUTICS
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 18, 2023 | $110,000 | Replaced |
| 4th Quarter - Amendment | Jan 19, 2023 | $110,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Mental Health Innovation at large substances - Cares Act. Telehealth and controlled substance prescribing habits for serious mental illness. Extension of Public Health Emergency Act for telehealth. Senate drug pricing reforms under Medicare Part D. TRIPS Waiver. H.R.5376 - Inflation Reduction Act of 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE GARNER | — |
| VANESSA PROCTER | — |
Medicare/Medicaid MMM
Senate drug pricing provisions and Medicare Part D reforms in reconciliation language. Telehealth Medicare physician reimbursement. H.R.4058/S.2061 - Telemental Health Care Access Act of 2021 to remove barriers to telemental health services for Medicare beneficiaries. H.R.5376 - Inflation Reduction Act of 2022.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE GARNER | — |
| VANESSA PROCTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.